XBP1 and cancer: Activation of IRE1α–XBP1 has been shown to stimulate the release of cathepsins by macrophages in in vitro studies, thus promoting the invasion of cancer cells; this process can be blocked by inhibitors of IRE1α, reducing the tumor invasion caused by macrophages [96].